Human Organoids Market, By Product (Media & Supplements, Reagents, Organoid Models and Others), By Source, By Type, By Disease Area, By Application, By End User, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
|
Report ID
ANV6319
|
Published Date
November 2026
|
Pages
308
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Human Organoids Market size was valued at US$ 1,380.9 Million in 2025, expanding at a CAGR of 14.5% from 2026 to 2033.
Human organoids are 3D laboratory-grown entities derived from human stem cells or cells extracted from human tissue that resemble the essential features and functions of human organs like the liver, kidney, pancreas, colon, heart, and lungs. Human organoids are employed in research to investigate human diseases, human organ development, drug discovery, and treatment response evaluation. Human organoids are able to mimic essential structural and functional features of human tissues, unlike traditional 2D cell cultures.
Human organoids are usually grown using stem cell technology and various cultivation techniques like Matrigel matrix, air-liquid interface, suspension, and 3D bioprinting. They can be purchased as off-the-shelf models and customized models according to research needs. These models are increasingly used by pharmaceutical companies, biotechnology companies, academic institutions, and research laboratories.
Human Organoids Market- Market Dynamics
Advancements in Stem Cell Research to Fuel Market Expansion
The growing advancements in stem cell research have caused the need for the use of human organoids because they help researchers understand human tissue development, disease models, drug reactions, and regenerative medicine applications. In May 2025, as reported by Stem Cell Donors Australia Org, nearly 1,300 Australians required an unrelated stem cell donor, showing a 47% increase. There were 93,710 successful donors within the age group of 18 to 35 years, reflecting a 25% increase compared to the previous year and a 108% increase overall. Also, 164 Australians had donated their stem cells in 2025, which was about 50% higher, and 505 Australians had received transplants. This is the highest number of transplants ever recorded. This shows that there has been progress in stem cell research because of an increase in donors and benefits to many people.
Human Organoids Market- Segmentation Analysis:
The Global Human Organoids Market is segmented on the basis of Product, Source, Organ Type, Disease Area, Application, End User, and Region.
In the human organoid market, oncology holds a significant share due to the increase in incidence of cancer, personalized medicine, and the use of patient-derived organoids for cancer studies, drug screening, and assessing treatment response. In August 2026, ATCC announced a new development regarding the newly published peer-reviewed study that indicates that the Human Cancer Models Initiative organoid panel by ATCC has been successfully validated. The study showed that patient-derived human organoid models possessed the features of the original human tumor, including genetics, epigenetics, and biological properties. This is boosting the role of human organoids in cancer research, personalized treatment, and precision oncology.
Human Organoids Market- Geographical Insights
North America holds a considerable position in the Human Organoids market due to many big pharmaceutical and biotechnology firms, along with reputed research institutions and increased investment in stem cell research. For instance, in September 2026, according to the Government of Canada, the government invested USD 48.3 million in their Life Sciences Fund for the advancement of Canada’s life sciences industry and research capabilities and biomanufacturing. Out of the total investment, USD 2.02 million will be granted to STEMCELL Technologies in connection with their USD 2.09 million projects aimed at developing a local process for making customized cell culture media. Moreover, USD 1.12 million has also been invested by the Canadian government in 5 pan-Canadian research hubs over 3 years. These investments aim to enhance Canada\'s domestic biomanufacturing capabilities, strengthen research infrastructure, and reduce reliance on foreign supply chains.
Human Organoids Market- Competitive Landscape:
The Human Organoids market consists of companies involved in creating organoid models along with cell culture products, lab supplies, and advanced 3D cell culture techniques. metabolism, companies are focused on improving the quality of their organoid models, creating novel culture products, and helping in pharmaceutical reindustry and drug development. In February 2026, Cherry Biotech and Cytion entered into a strategic partnership providing access to more than 800 cell lines, which will be used to develop OrganoidPlate from Cherry Biotech. The partnership will help improve the development of human-relevant organoid models.
Recent Developments:
In August 2026, Molecular Devices and HeartBeat.bio announced that their 3D Ready Cardioid Supplement Kit will be available soon. The kit uses cardiac organoid technology to create reproducible cardiac models using automation laboratory workflows to support the development of reproducible cardiac models for drug discovery and safety testing.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL HUMAN ORGANOIDS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- ATCC
- Merck KGaA
- Bio-Techne
- STEMCELL Technologies
- Corning Incorporated
- Thermo Fisher Scientific Inc.
- ACROBiosystems
- PRIMACYT Cell Culture Technology GmbH
- AMSBIO
- Qkine Ltd.
- Sartorius AG
- Greiner Bio-One International GmbH
- Prellis Biologics
- Xilis, Inc.
- BioIVT
- REPROCELL Inc.
- Others
GLOBAL HUMAN ORGANOIDS MARKET, BY PRODUCT- MARKET ANALYSIS, 2020 - 2033
- Media & Supplements
- Reagents
- Organoid Models
- Others
GLOBAL HUMAN ORGANOIDS MARKET, BY SOURCE- MARKET ANALYSIS, 2020 - 2033
- Embryonic Stem Cells
- Adult Stem Cells
- Induced Pluripotent Stem Cells (iPSCs)
- Others
GLOBAL HUMAN ORGANOIDS MARKET, BY ORGAN TYPE- MARKET ANALYSIS, 2020 - 2033
- Lung Models
- Brain Models
- Kidney Models
- Stomach Models
- Intestine Models
- Liver Models
- Pancreatic Models
- Others
GLOBAL HUMAN ORGANOIDS MARKET, BY DISEASE AREA- MARKET ANALYSIS, 2020 - 2033
- Oncology
- Neurological Disorders
- Liver Diseases
- Cardiovascular Diseases
- Gastrointestinal Diseases
- Infectious Diseases
- Others
GLOBAL HUMAN ORGANOIDS MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- Personalized Medicine
- Developmental Biology
- Disease Pathology
- Drug Toxicity & Efficacy Testing
- Regenerative Medicine
- Others
GLOBAL HUMAN ORGANOIDS MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033
- Contract Research Organizations
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- Others
GLOBAL HUMAN ORGANOIDS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Denmark
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Taiwan
- Vietnam
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Iran
- Qatar
- Rest of MEA
TABLE OF CONTENT
1. Human Organoids Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.2. Competitive Insights
3. Human Organoids Key Market Trends
3.1. Human Organoids Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Human Organoids Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Human Organoids Market Opportunities
3.4. Human Organoids Market Future Trends
4. Human Organoids Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Human Organoids Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Human Organoids Market Landscape
6.1. Human Organoids Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Human Organoids Market – By Product
7.1. Overview
7.1.1. Segment Share Analysis, By Product, 2025 & 2033 (%)
7.1.2. Media & Supplements
7.1.3. Reagents
7.1.4. Organoid Models
7.1.5. Others
8. Human Organoids Market – By Source
8.1. Overview
8.1.1. Segment Share Analysis, By Source, 2025 & 2033 (%)
8.1.2. Embryonic Stem Cells
8.1.3. Adult Stem Cells
8.1.4. Induced Pluripotent Stem Cells (iPSCs)
8.1.5. Others
9. Human Organoids Market – By Organ Type
9.1. Overview
9.1.1. Segment Share Analysis, By Organ Type, 2025 & 2033 (%)
9.1.2. Lung Models
9.1.3. Brain Models
9.1.4. Kidney Models
9.1.5. Stomach Models
9.1.6. Intestine Models
9.1.7. Liver Models
9.1.8. Pancreatic Models
9.1.9. Others
10. Human Organoids Market – By Disease Area
10.1. Overview
10.1.1. Segment Share Analysis, By Disease Area, 2025 & 2033 (%)
10.1.2. Oncology
10.1.3. Neurological Disorders
10.1.4. Liver Diseases
10.1.5. Cardiovascular Diseases
10.1.6. Gastrointestinal Diseases
10.1.7. Infectious Diseases
10.1.8. Others
11. Human Organoids Market – By Application
11.1. Overview
11.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
11.1.2. Personalized Medicine
11.1.3. Developmental Biology
11.1.4. Disease Pathology
11.1.5. Drug Toxicity & Efficacy Testing
11.1.6. Regenerative Medicine
11.1.7. Others
12. Human Organoids Market – By End User
12.1. Overview
12.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
12.1.2. Contract Research Organizations
12.1.3. Academic & Research Institutes
12.1.4. Pharmaceutical & Biotechnology Companies
12.1.5. Others
13. Human Organoids Market – By Geography
13.1. Introduction
13.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
13.2. North America
13.2.1. Overview
13.2.2. Human Organoids Key Manufacturers in North America
13.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
13.2.4. North America Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
13.2.5. North America Market Size and Forecast, By Source, 2020 - 2033 (US$ Million)
13.2.6. North America Market Size and Forecast, By Organ Type, 2020 - 2033 (US$ Million)
13.2.7. North America Market Size and Forecast, By Disease Area, 2020 - 2033 (US$ Million)
13.2.8. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
13.2.9. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13.2.10. U.S.
13.2.11. Canada
13.3. Europe
13.3.1. Overview
13.3.2. Human Organoids Key Manufacturers in Europe
13.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
13.3.4. Europe Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
13.3.5. Europe Market Size and Forecast, By Source, 2020 - 2033 (US$ Million)
13.3.6. Europe Market Size and Forecast, By Organ Type, 2020 - 2033 (US$ Million)
13.3.7. Europe Market Size and Forecast, By Disease Area, 2020 - 2033 (US$ Million)
13.3.8. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
13.3.9. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13.3.10. Germany
13.3.11. UK
13.3.12. France
13.3.13. Italy
13.3.14. Spain
13.3.15. The Netherlands
13.3.16. Sweden
13.3.17. Russia
13.3.18. Poland
13.3.19. Denmark
13.3.20. Rest of Europe
13.4. Asia Pacific (APAC)
13.4.1. Overview
13.4.2. Human Organoids Key Manufacturers in Asia Pacific
13.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
13.4.4. APAC Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
13.4.5. APAC Market Size and Forecast, By Source, 2020 - 2033 (US$ Million)
13.4.6. APAC Market Size and Forecast, By Organ Type, 2020 - 2033 (US$ Million)
13.4.7. APAC Market Size and Forecast, By Disease Area, 2020 - 2033 (US$ Million)
13.4.8. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
13.4.9. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13.4.10. China
13.4.11. India
13.4.12. Japan
13.4.13. South Korea
13.4.14. Australia
13.4.15. Indonesia
13.4.16. Thailand
13.4.17. Philippines
13.4.18. Taiwan
13.4.19. Vietnam
13.4.20. Rest of APAC
13.5. Latin America (LATAM)
13.5.1. Overview
13.5.2. Human Organoids Key Manufacturers in Latin America
13.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
13.5.4. LATAM Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
13.5.5. LATAM Market Size and Forecast, By Source, 2020 - 2033 (US$ Million)
13.5.6. LATAM Market Size and Forecast, By Organ Type, 2020 - 2033 (US$ Million)
13.5.7. LATAM Market Size and Forecast, By Disease Area, 2020 - 2033 (US$ Million)
13.5.8. LATAM Size and Forecast, By Application, 2020 - 2033 (US$ Million)
13.5.9. LATAM Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13.5.10. Brazil
13.5.11. Mexico
13.5.12. Argentina
13.5.13. Colombia
13.5.14. Rest of LATAM
13.6. Middle East and Africa
13.6.1. Overview
13.6.2. Human Organoids Key Manufacturers in Middle East and Africa
13.6.3. Middle East and Africa Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
13.6.4. Middle East and Africa Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
13.6.5. Middle East and Africa Market Size and Forecast, By Source, 2020 - 2033 (US$ Million)
13.6.6. Middle East and Africa Market Size and Forecast, By Organ Type, 2020 - 2033 (US$ Million)
13.6.7. Middle East and Africa Market Size and Forecast, By Disease Area, 2020 - 2033 (US$ Million)
13.6.8. Middle East and Africa Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
13.6.9. Middle East and Africa Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13.6.10. Saudi Arabia
13.6.11. UAE
13.6.12. Israel
13.6.13. Turkey
13.6.14. Algeria
13.6.15. Egypt
13.6.16. Iran
13.6.17. Qatar
13.6.18. Rest of MEA
14. Key Vendor Analysis- Human Organoids Industry
14.1. Competitive Benchmarking
14.1.1. Competitive Dashboard
14.1.2. Competitive Positioning
14.2. Company Profiles
14.2.1. ATCC
14.2.2. Merck KGaA
14.2.3. Bio-Techne
14.2.4. STEMCELL Technologies
14.2.5. Corning Incorporated
14.2.6. Thermo Fisher Scientific Inc.
14.2.7. ACROBiosystems
14.2.8. PRIMACYT Cell Culture Technology GmbH
14.2.9. AMSBIO
14.2.10. Qkine Ltd.
14.2.11. Sartorius AG
14.2.12. Greiner Bio-One International GmbH
14.2.13. Prellis Biologics
14.2.14. Xilis, Inc.
14.2.15. BioIVT
14.2.16. REPROCELL Inc.
14.2.17. Others
15. 360 Degree AnalystView
16. Appendix
16.1. Research Methodology
16.2. References
16.3. Abbreviations
16.4. Disclaimer
16.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL HUMAN ORGANOIDS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- ATCC
- Merck KGaA
- Bio-Techne
- STEMCELL Technologies
- Corning Incorporated
- Thermo Fisher Scientific Inc.
- ACROBiosystems
- PRIMACYT Cell Culture Technology GmbH
- AMSBIO
- Qkine Ltd.
- Sartorius AG
- Greiner Bio-One International GmbH
- Prellis Biologics
- Xilis, Inc.
- BioIVT
- REPROCELL Inc.
- Others
GLOBAL HUMAN ORGANOIDS MARKET, BY PRODUCT- MARKET ANALYSIS, 2020 - 2033
- Media & Supplements
- Reagents
- Organoid Models
- Others
GLOBAL HUMAN ORGANOIDS MARKET, BY SOURCE- MARKET ANALYSIS, 2020 - 2033
- Embryonic Stem Cells
- Adult Stem Cells
- Induced Pluripotent Stem Cells (iPSCs)
- Others
GLOBAL HUMAN ORGANOIDS MARKET, BY ORGAN TYPE- MARKET ANALYSIS, 2020 - 2033
- Lung Models
- Brain Models
- Kidney Models
- Stomach Models
- Intestine Models
- Liver Models
- Pancreatic Models
- Others
GLOBAL HUMAN ORGANOIDS MARKET, BY DISEASE AREA- MARKET ANALYSIS, 2020 - 2033
- Oncology
- Neurological Disorders
- Liver Diseases
- Cardiovascular Diseases
- Gastrointestinal Diseases
- Infectious Diseases
- Others
GLOBAL HUMAN ORGANOIDS MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- Personalized Medicine
- Developmental Biology
- Disease Pathology
- Drug Toxicity & Efficacy Testing
- Regenerative Medicine
- Others
GLOBAL HUMAN ORGANOIDS MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033
- Contract Research Organizations
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- Others
GLOBAL HUMAN ORGANOIDS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Denmark
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Taiwan
- Vietnam
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Iran
- Qatar
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Analystview Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
